Rachel K. King, Director at NOVAVAX INC (NVAX), bought 64,000 shares at $0.53 ($34K) on 2019-03-27, disclosed to the SEC on 2019-03-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.53 | 22,000 | $12K | 34.4% |
| 2 | $0.53 | 42,000 | $22K | 65.6% |
| Total | $0.53 avg | 64,000 | $34K | 100% |
| Filing → |
| GLYC | SELL | 2020-12-30 | $658K | — | Filing → |